Sofinnova Investments
Overview
Sofinnova Investments is a healthcare investment firm committed to funding innovative products that aspire to meaningfully impact the lives of patients . The firm actively partners with entrepreneurs across all stages of company formation . Sofinnova invests in late preclinical and clinical therapeutic companies across the U.S. and Europe . Key therapeutic areas include oncology, respiratory, dermatology, ophthalmology, neurology and women's health .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Coultreon Biopharma | Apr 2026 | Series A | Lead |
| Aeovian Pharmaceuticals | Dec 2025 | Series B | Co-investor |
| Expedition Therapeutics | Oct 2025 | Series A | Lead |
| Avenzo Therapeutics | Sep 2025 | Series B | Co-investor |
| ARTBIO | Jul 2025 | Series B | Lead |
Key People
James H.
Managing Partner
Eric Delbridge
General Partner
Maha Katabi
General Partner
Sarah Bhagat
General Partner
Goro Takeda
Venture Partner
Chris Carpenter
Executive Partner
Jakob Dupont
Executive Partner
Jonathan Leff
Executive Partner
Lars Ekman
Excecutive Partner
Perry Nisen
Executive Partner
Remy Aubert
Partner
Nathalie Auber
Partner And CFO
Aneal Tenjarla
Associate Portfolio Manager
Nick Lenard
Healthcare Investor
Peng Li
Healthcare Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
